Literature DB >> 16402087

Three years of promise, proposals, and progress on optimizing the benefit/risk of medicines: a commentary on the 3rd FDA-DIA-PWG-PhRMA-BIO pharmacogenomics workshop.

R A Salerno1, L J Lesko.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16402087     DOI： 10.1038/sj.tpj.6500345

Source DB:  PubMed          Journal:  Pharmacogenomics J        ISSN： 1470-269X            Impact factor:   3.550


× No keyword cloud information.
  2 in total

1.  Clinical implementation of genetic testing in medicine: a US regulatory science perspective.

Authors:  Lawrence J Lesko; Stephan Schmidt
Journal:  Br J Clin Pharmacol       Date:  2014-04       Impact factor: 4.335

2.  FDA perspectives on potential microarray-based clinical diagnostics.

Authors:  Zivana Tezak; Daya Ranamukhaarachchi; Estelle Russek-Cohen; Steven I Gutman
Journal:  Hum Genomics       Date:  2006-01       Impact factor: 4.639
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.